NAMS Reports $707.3M Cash, $19B Net Income, +94% YoY, Announces 2H26 EMA Approval, 4Q26 Menarini Launch, 4Q26 PREVAIL Interim, 1Q27 Result, RUBENS Data Year-End 2026
NewAmsterdam Pharma Company N.V. Ordinary Shares · PHARMACEUTICAL PREPARATIONS · Now $31.79
+12% in 3d after detection
Post-detection moves
1h
—
1d
+11%
3d
+12%
7d
-2.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS